Profound Medical (PROF) Operating Income Growth (3y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn | -46.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.95% |
| Dec 31, 2025 | 35.66% |
| Sep 30, 2025 | -45.53% |
| Jun 30, 2025 | -55.71% |
| Mar 31, 2025 | -52.28% |
| Dec 31, 2024 | 45.25% |
| Sep 30, 2024 | -47.10% |
| Jun 30, 2024 | -47.80% |
| Mar 31, 2024 | -47.34% |
| Dec 31, 2023 | -65.95% |
| Sep 30, 2023 | 8.46% |
| Jun 30, 2023 | 17.77% |
| Mar 31, 2023 | 11.96% |
| Dec 31, 2022 | -78.83% |
| Sep 30, 2022 | 21.46% |
| Jun 30, 2022 | 22.96% |
| Mar 31, 2022 | 52.77% |